ALB and pancreatic neoplasm: Okamoto et al. reported that a paclitaxel-albumin complex-encapsulated liposome greatly suppressed the growth of AsPC-1 human pancreatic cancer compared to nab-paclitaxel (Abraxane®) in xenograft tumor-bearing mice [84].